# Jet Injection for Influenza

> **NCT01688921** · PHASE4 · COMPLETED · sponsor: **PharmaJet, Inc.** · enrollment: 1250 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** AFLURIA vaccine (2012-2013 formulation)
- **DEVICE:** Needle-Syringe
- **DEVICE:** Stratis needle-free injection device

## Key facts

- **NCT ID:** NCT01688921
- **Lead sponsor:** PharmaJet, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 1250 (ACTUAL)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688921, "Jet Injection for Influenza". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT01688921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*